CMPX · Compass Therapeutics, Inc. · Investor Relations
$0.99
+0.01 (+0.98%)
At close · Oct 9
Return incl. dividend (before tax)
Market Cap
$178.83M
Shares
180.09M
Volume · Oct 9
3.67M
Avg daily vol (3M)
4.14M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-09 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-20 | 2026 Stifel Virtual Targeted Oncology Forum | Webcast |
| 2026-05-19 | H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ | Conference |
| 2026-04-27 | Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer | Webcast |
| 2026-01-14 | J.P. Morgan 2026 Healthcare Conference | Conference |
| 2025-11-12 | Stifel 2025 Healthcare Conference | Conference |
| 2025-11-10 | Guggenheim Second Annual Healthcare Innovation Conference | Conference |